Some 2.6 million UK residents have diabetes and this number is rising. These people are at increased risk of heart disease, blindness and limb amputation. It is important to know the difference between Type I and Type II diabetes and how they can be managed to avoid these serious long-term complications. In this special report, you can find recent news and relevant articles about diabetes, including information about the condition and the treatment for it.
Pharmaceutical company AstraZeneca has released mixed news about the performance in clinical trials of two of its products: benralizumab for severe asthma and non-insulin diabetes drug Bydureon.
The drug regulator in the United States has issued a warning on diabetes drug canagliflozin after two large clinical trials found that it was associated with an increased risk of leg and foot amputations.
Pharmacist intervention led to better blood pressure, glycated haemoglobin and total cholesterol scores for patients with type 2 diabetes, study shows.
Study results raise hope that omega-3 polyunsaturated fatty acids found in fish oil may be able to reverse type 1 diabetes.
Wearable patch successfully delivered metformin under the skin of mice and reduced blood glucose levels, offering a system researchers say could be used in clinical settings as a treatment for diabetes.
The war with body fatSubscription
The secret life of fat, by Sylvia Tara
Researchers say that older women taking statins should be regularly monitored after discovering that the risk of diabetes increased the higher the dose of statin in a cohort of 8,372 patients.
The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates drugs and devices in the UK, has updated its advice concerning the increased risk of lower limb amputation associated with canaglifozin, a drug used to treat type 2 diabetes.
For the seventh year running, the National Paediatric Diabetes Audit shows that children living with diabetes are being helped to manage their blood glucose levels (HbA1c) and so reduce the risk of developing ...
English Pharmacy Board meeting: 26 January 2017Subscription
The English Pharmacy Board (EPB) met for its first board meeting of the year on 26 January 2017, at the Royal Pharmaceutical Society (RPS)’s London headquarters in Wapping, east London.
Photopharmacology: using light to activate drugsSubscription
Drugs that contain synthetic light-switching molecules could help target therapies to particular parts of the body, limiting side effects. Researchers have started using this approach to tackle blindness, cancer, diabetes, and antibiotic resistance, but questions remain about the clinical practicality of the field.
Building a case on the harm of sugarSubscription
The case against sugar, by Gary Taubes
The challenges of managing diabetes at mealtimesSubscription
Dextrose gel prevents hypoglycaemia in newbornsSubscription
Local practice forum event: 21 SeptemberSubscription